KDEVF (KDventures AB) Valuation Rank


KDEVF KDventures AB KDEVF
30 GF Score
Price $0.26
GF Value $0.67
! 3 Warning Signs
View Full Analysis

What is KDventures AB Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

KDventures AB Valuation Rank Related Terms

KDEVF
30GF Score
KDventures AB KDEVF
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is KDventures AB (KDEVF) Overvalued in 2026?

Based on GuruFocus' analysis, KDventures AB stock appears to be undervalued. The current stock price of $0.26 is trading 61.6% below its estimated GF Value™ of $0.67.

Key valuation signals for KDEVF:

  • Valuation Rank:
  • GF Value™: $0.67 vs. price of $0.26 (61.6% below fair value)
  • GF Score™: 30/100 with 3 warning signs

No single metric tells the full story. See the KDEVF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

KDventures AB Business Description

Address Nanna Svartz vag 6A, Solna, SWE, 171 65
KDventures AB is a Nordic investment company specialized in life sciences. The company identifies and invests in pharmaceutical projects and medical technology products originating from research institutions in the Nordic region. Through a diversified portfolio across various stages of development, professional due diligence, and active board engagement, the company creates value from early research to commercialization. The company offers investors exposure to both listed and private life science projects with value growth potential.
30GF Score

Get the complete analysis for KDEVF

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.26
Price
$0.67
GF Value